Milos Miljkovic

9PUBLICATIONS
25CO-AUTHORS
Regenerative medicine (incl. stem cells)Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Cellular immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 29, 2025
mRNA engineering of allogeneic mesenchymal stem cells enables coordinated delivery of T cell engagers and immunotherapeutic cues.

C Andrew Stewart, Shaji Daniel, Elizabeth J Curvino

|Aug 26, 2025
Durability of Response to B-Cell Maturation Antigen-Directed mRNA Cell Therapy in Myasthenia Gravis.

Nizar Chahin, Gregory Sahagian, Marc H Feinberg

|Oct 30, 2024
Engineering CAR-T therapies for autoimmune disease and beyond.

Emily P English, Rachel N Swingler, Simran Patwa

|Sep 06, 2022
Methodological and conceptual challenges to the flow cytometric classification of leukemic lymphoproliferative disorders.

Nadia Güell, Pablo Mozas, Alba Jimenez-Rueda

|Apr 27, 2022
Interleukin-15 augments NK cell-mediated ADCC of alemtuzumab in patients with CD52+ T-cell malignancies.

Milos D Miljkovic, Sigrid P Dubois, Jürgen R Müller

|Jan 14, 2022
Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphoma.

Anusara Daenthanasanmak, Richard N Bamford, Makoto Yoshioka

Pageof 2

Frequent Collaborators

2 joint publications

Christopher M Jewell

2 joint publications

Emily P English

2 joint publications

James F Howard

1 joint publications

Christopher Melani